Article info
PDFResearch ethics
Paper
Post-trial period surveillance for randomised controlled cardiovascular studies: submitted protocols, consent forms and the role of the ethics board
- Correspondence to Dr Mohammad I Zia, Division of Cardiology, 2075 Bayview Avenue, Room B327, Sunnybrook Health Sciences Centre, Toronto, ON, Canada M4N 3M5; mo.zia{at}utoronto.ca
Citation
Post-trial period surveillance for randomised controlled cardiovascular studies: submitted protocols, consent forms and the role of the ethics board
Publication history
- Received February 21, 2011
- Revised May 25, 2011
- Accepted June 5, 2011
- First published June 23, 2011.
Online issue publication
November 21, 2011
Article Versions
- Previous version (23 June 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Institutional conflict of interest: attempting to crack the deferiprone mystery
- Failure to report and provide commentary on research ethics board approval and informed consent in medical journals
- FLUID trial: a protocol for a hospital - wide open - label cluster crossover pragmatic comparative effectiveness randomised pilot trial
- Study protocol for two complementary trials of non-steroidal or opioid analgesia use for children aged 6 to 17 years with musculoskeletal injuries (the No OUCH study)
- Access to medical records for research purposes: varying perceptions across research ethics boards
- Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo - controlled study
- Feasibility of conducting prospective observational research on critically ill, dying patients in the intensive care unit
- Lithium for Fracture Treatment (LiFT): a double - blind randomised control trial protocol
- [18F] DCFPyL PET - MRI / CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative - intent ablative therapy: study protocol for a phase II trial
- A protocol for a Canadian prospective observational study of decision - making on active surveillance or surgery for low - risk papillary thyroid cancer